Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF

被引:33
|
作者
Funaoka, K
Shindoh, M
Yoshida, K
Hanzawa, M
Hida, K
Nishikata, S
Totsuka, Y
Fujinaga, K
机构
[1] HOKKAIDO UNIV, SCH DENT, DEPT ORAL PATHOL, KITA KU, SAPPORO, HOKKAIDO 060, JAPAN
[2] HOKKAIDO UNIV, SCH DENT, DEPT ORAL SURG 2, SAPPORO, HOKKAIDO 060, JAPAN
[3] SAPPORO MED UNIV, SCH MED, CANC RES INST, DEPT BIOL MOL, SAPPORO, HOKKAIDO 060, JAPAN
关键词
D O I
10.1006/bbrc.1997.6909
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p21(Waf1/Cip1) is one of the key regulatory proteins in cell cycle, terminal differentiation, and apoptosis. Its promoter was shown to be transactivated by the wild-type p53 protein as well as in a p53-independent manner. In this report, we demonstrate that E1AF, an ets-related transcription factor, activated the human p21(Waf1/Cip1) promoter by interacting with the ets-binding sites located close to the two previously identified p53-responsive elements. Northern blot analysis revealed that p21(Waf1/Cip1) and E1AF were correlatively upregulated in response to cisplatin treatment in SiHa cells. Transient expression assays demonstrated that E1AF can activate the p21(Waf1/Cip1) promoter-driven luciferase reporter gene in SiHa cells. The p21(Waf1/Cip1) promoter activity was also increased in p53-null Saos2 osteosarcoma cells, but was markedly reduced when the ets-binding sites were deleted. These results indicate that E1AF positively regulates transcription from the p21(Waf1/Cip1) promoter in response to genotoxic stresses. (C) 1997 Academic Press.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 50 条
  • [41] TOPOLOGICAL CONTROL OF P21(WAF1/CIP1) EXPRESSION IN NORMAL AND NEOPLASTIC TISSUES
    ELDEIRY, WS
    TOKINO, T
    WALDMAN, T
    OLINER, JD
    VELCULESCU, VE
    BURRELL, M
    HILL, DE
    HEALY, E
    REES, JL
    HAMILTON, SR
    KINZLER, KW
    VOGELSTEIN, B
    CANCER RESEARCH, 1995, 55 (13) : 2910 - 2919
  • [42] p21(Waf1/Cip1) and p53 protein expression in breast cancer
    Wakasugi, E
    Kobayashi, T
    Tamaki, Y
    Ito, Y
    Miyashiro, I
    Komoike, Y
    Takeda, T
    Shin, E
    Takatsuka, Y
    Kikkawa, N
    Monden, T
    Monden, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (06) : 684 - 691
  • [43] TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response
    Pisonero-Vaquero, Sandra
    Soldati, Chiara
    Cesana, Marcella
    Ballabio, Andrea
    Medina, Diego Luis
    CELLS, 2020, 9 (05)
  • [44] Regulation of p21(WAF1/CIP1) expression by p53-independent pathways
    Zeng, YX
    ElDeiry, WS
    ONCOGENE, 1996, 12 (07) : 1557 - 1564
  • [45] p53/p21((waf1/cip1)) expression in human lung cancer
    Bennett, WP
    ElDeiry, WS
    Guinee, DG
    Caporaso, NE
    Welsh, JA
    Jones, RT
    Borkowski, A
    Travis, WD
    Colby, TV
    Trastek, V
    Pairolero, PC
    Tazelaar, HF
    Midthun, D
    Jett, JR
    Liotta, LA
    Vogelstein, B
    Harris, CC
    LABORATORY INVESTIGATION, 1996, 74 (01) : 895 - 895
  • [46] INCREASED LEVELS OF P21(WAF1/CIP1) IN HUMAN BRAIN-TUMORS
    JUNG, JM
    BRUNER, JM
    RUAN, SB
    LANGFORD, LA
    KYRITSIS, AP
    KOBAYASHI, T
    LEVIN, VA
    ZHANG, W
    ONCOGENE, 1995, 11 (10) : 2021 - 2028
  • [47] Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer
    Tang, Kun
    Wang, Chenghe
    Chen, Zhong
    Xu, Hua
    Ye, Zhangqun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 4999 - 5007
  • [48] Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers
    Papandreou, CN
    Bogenrieder, T
    Loganzo, F
    Albino, AP
    Nanus, DM
    UROLOGY, 1997, 49 (03) : 481 - 486
  • [49] p21(WAF1/CIP1) expression in non-melanoma skin tumors
    Ahmed, NU
    Ueda, M
    Ichihashi, M
    JOURNAL OF CUTANEOUS PATHOLOGY, 1997, 24 (04) : 223 - 227
  • [50] Iron availability influences binding of multiple transcription factors to the p21(WAF1/CIP1) gene promoter during myelopoiesis.
    Alcantara, O
    Guo, Y
    Boldt, DH
    BLOOD, 2003, 102 (11) : 159B - 159B